STOK CapEx to Revenue

Stoke Therapeutics Inc · CapEx to Revenue

STOK logo

STOK CapEx to Revenue

Current (TTM)9.76%
STOK CapEx/Revenue (0.00% → 9.76%)
High-resolution chart · PNG

STOK capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.3633%
0.5553%
18.4055%
31.9387%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.